Prevention and Management of Cardiovascular Disease in Primary Care: A Comment on the PEER Simplified Lipid Guideline

In Canada, 2 guidelines provide guidance for the management of dyslipidemia. The Patients, Experience, Evidence, Research simplified lipid guidelines, intended for primary care practitioners, and the Canadian Cardiovascular Society guidelines, intended for all practitioners, are based on differing m...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:CJC open (Online) 2024-10, Vol.6 (10), p.1189-1198
Hauptverfasser: Mancini, G.B. John, Pearson, Glen J., Barry, Arden R., Couture, Patrick, Dayan, Natalie, Francis, Gordon A., Genest, Jacques, Gregoire, Jean C., Hegele, Robert A., Leiter, Lawrence A., Leung, Alexander A., Lonn, Eva, Manjoo, Priya, Ngui, Daniel, Piché, Marie-Eve, Poirier, Paul, Sievenpiper, John L., Thanassoulis, George, Ward, Richard
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:In Canada, 2 guidelines provide guidance for the management of dyslipidemia. The Patients, Experience, Evidence, Research simplified lipid guidelines, intended for primary care practitioners, and the Canadian Cardiovascular Society guidelines, intended for all practitioners, are based on differing methodologies with distinct priorities and preferences. The disparate approaches may contribute to confusion among family practitioners and their co-managed patients, with the potential for compromised care, differing standards for training in the fundamentals of lipidology, and differing criteria that might be used in practice audits to evaluate quality of care. The Patients, Experience, Evidence, Research (PEER) recommendations were considered by primary authors of the Canadian Cardiovascular Society guideline to identify areas of concordance, discordance, or agreement with qualifications. Discordance between the guidelines is greatest with respect to interpretation of the cholesterol profile, the implications of elevated triglyceride, the utility of apolipoprotein B and non-high-density lipoprotein-cholesterol measurements, the role of nonstatin medications, and the importance of assuring adherence and avoiding undertreatment through follow-up measurement of lipid profiles. The disparate importance attached to identification of patients with enhanced risk due to an elevated lipoprotein (a) level is also apparent. This comparison attempts to reconcile key principles of practice, to foster both high quality of care and fully informed patient-centred decision-making. Au Canada, deux lignes directrices régissent la prise en charge de la dyslipidémie. Les lignes directrices simplifiées sur les lipides: Patients, Experience, Evidence, Research, destinées aux praticiens de soins primaires, et les lignes directrices de la Société cardiovasculaire du Canada (SCC), destinées à tous les praticiens, sont basées sur des méthodologies différentes avec des priorités et des préférences distinctes. Des approches disparates peuvent contribuer à la confusion parmi les médecins de famille et leurs patients co-gérés, avec le risque de compromettre les soins, les normes de formation aux principes fondamentaux de la lipidologie et des critères différents qui pourraient être utilisés dans les audits de pratique pour évaluer la qualité des soins. Les recommandations de Patients, Experience, Evidence, Research (PEER) ont été examinées par les principaux auteurs des lignes directrices d
ISSN:2589-790X
2589-790X
DOI:10.1016/j.cjco.2024.06.006